MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Immunodiagnostic System receives FDA Emergency Use Authorization for Covid-19 test

StockMarketWire.com

Laboratory diagnostic market solutions provider Immunodiagnostic System said it had reached a agreement with its partner Technogenetics to receive Covid-19 tests that had been grated FDA Emergency Use Authorization.

Immunodiagnostic System would now be able to 'sell the test to laboratories in the USA for clinical testing purposes,' the company said.

The test exceeded the FDA's sensitivity and specificity requirements for laboratory run serology tests.







Story provided by StockMarketWire.com